Tirzepatide
Composition
Each single dose pen contains 0.5 ml solution of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg tirzepatide with the following excipients: sodium chloride 4.1 mg, sodium phosphate dibasic heptahydrate 0.7 mg, and water for injection.
Indications
It is indicated to control high blood sugar levels in patients with type 2 diabetes
Side effects
Mild to moderate side effect has been observed such as Dyspepsia, Decreased appetite, blurred vision, and joint pain.
Precautions
Kidney or pancreas disease, a history of diabetic retinopathy or any stomach problem, pregnant or breastfeeding
Contraindications
It is contraindicated in people with Medullary thyroid cancer Multiple endocrine neoplasia syndrome Diabetic retinopathy disease of the gallbladder, pancreatitis type 1 diabetes mellitus.
Dosage and administration
In adults 2.5 mcg dose is administrated subcutaneously once a week. The maximum dosage is 15mg.
Countries
We have also established roots and begun this new venture in other countries as well such as Bahrain, France , Argentina, Brazil, and Finland